CSL Behring States Stimate Will Not Be Resupplied until 2022

NHF and HFA have been provided the following statement from CSL Behring.

The statement says, in part: “Ferring Pharmaceuticals Inc. initiated a voluntary, consumer-level recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL, which is distributed and sold by CSL Behring LLC. At this time, Ferring does not anticipate resupply before 2022.”

NHF and HFA remind you to please reach out to your physician with any medical concerns. You can also contact CSL Behring’s Medical Information Phone Line at 1-800-504-5434.

Please note that NHF and HFA do not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, treatments or opinions. If you have any questions or concerns about your medical treatment, including your possible exposure to recalled product, please consult your physician. Events like this one can cause a myriad of emotions. Please reach out to a social worker, provider, or trusted source of support.

Source: National Hemophilia Foundation

Back to all News